|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 185.68 USD | +1.45% |
|
+6.15% | +101.98% |
| 01:52am | ASTRAZENECA : Gets a Buy rating from Jefferies | ZD |
| Jun. 25 | Major deals involving US drugmakers and biotechs over the past decade | RE |
| Market Cap | 288B 253B 233B 218B 409B 27,197B 417B 2,799B 1,084B 13,406B 1,082B 1,059B 46,589B | P/E 2026 * |
23.3x | P/E 2027 * | 20.3x |
|---|---|---|---|---|---|
| Enterprise Value | 307B 270B 249B 233B 436B 29,013B 444B 2,986B 1,156B 14,302B 1,155B 1,129B 49,700B | EV / Sales 2026 * |
4.86x | EV / Sales 2027 * | 4.47x |
| Free-Float |
96.63% | Yield 2026 * |
1.8% | Yield 2027 * | 1.9% |
Last Transcript: AstraZeneca PLC
| 1 day | +1.45% | ||
| Current month | +100.15% | ||
| 6 months | +99.87% | ||
| Current year | +101.98% |
| Current year | 89.04 |  | 186.58 |
| 1 year | 68.62 | | 186.58 |
| 3 years | 60.47 | | 186.58 |
| 5 years | 52.65 | | 186.58 |
| 10 years | 25.55 | | 186.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Pam Cheng
COO | Chief Operating Officer | 55 | 2015-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.45% | +6.15% | - | - | 288B | |
| +0.93% | +2.65% | +42.33% | +145.77% | 1,006B | |
| +1.61% | +7.22% | +60.81% | +47.98% | 589B | |
| +3.51% | +12.31% | +31.15% | +78.88% | 430B | |
| -0.75% | +5.11% | +29.26% | +21.27% | 331B | |
| -0.90% | +5.41% | +29.87% | +40.24% | 285B | |
| -1.84% | +5.79% | -28.09% | -42.34% | 213B | |
| +0.40% | +4.51% | +25.85% | +55.35% | 190B | |
| -1.05% | +0.06% | +16.91% | +59.86% | 154B | |
| -1.54% | -6.11% | -2.43% | -38.20% | 135B | |
| Average | +0.57% | +4.38% | +22.85% | +40.98% | 370.27B | |
| Weighted average by Cap. | +0.86% | +4.74% | +33.37% | +69.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.32B 55.62B 51.25B 47.92B 89.87B 5,975B 91.52B 615B 238B 2,945B 238B 233B 10,236B | 67.16B 58.99B 54.35B 50.82B 95.31B 6,337B 97.06B 652B 253B 3,124B 252B 247B 10,856B |
| Net income | 12.49B 10.97B 10.11B 9.45B 17.72B 1,178B 18.05B 121B 46.97B 581B 46.9B 45.87B 2,019B | 14.14B 12.42B 11.44B 10.7B 20.06B 1,334B 20.43B 137B 53.17B 658B 53.09B 51.93B 2,285B |
| Net Debt | 19.25B 16.91B 15.58B 14.56B 27.31B 1,816B 27.82B 187B 72.38B 895B 72.27B 70.69B 3,111B | 12.01B 10.55B 9.72B 9.08B 17.04B 1,133B 17.35B 117B 45.15B 558B 45.08B 44.1B 1,941B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-25 | $185.68 | +1.45% | 1,826,301 |
| 26-06-24 | $183.02 | +1.10% | 2,377,682 |
| 26-06-23 | $181.02 | +2.60% | 1,503,883 |
| 26-06-22 | $176.43 | +0.86% | 1,489,610 |
| 26-06-18 | $174.93 | -1.66% | 1,667,045 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
